Share on

Global Stem Cell Assay Market Size, Share, Trends, COVID-19 impact & Growth Analysis Report - Segmented By Assay Type, Kits, Application, End User & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 3530
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Stem Cell Assay Market Size (2022 to 2027)

The global stem cell assay market size was worth USD 793.74 million in 2022 and to grow USD 1983.32 million by 2027, witnessing a CAGR of 20.1% during the forecast period.

Stem cells are differentiated or partially differentiated into various cells that can divide infinitely to produce many similar stem cells. Stem cells play a crucial role in replacing damaged or defective cells. Stem cells have a totipotency property where they can differentiate into any cell present in the body. These are the main factors for establishing new generative treatment options as diagnostic tools that help in researching new drugs. Stem cells are a particular type of cells in the body that are not differentiated, but they can evolve into any other cell type. They divide and produce more cells, and hence they found a variety of stem cell applications in regenerative medicine.  Stem cell assays also help to identify toxic agents with similar sensitivity. Promega and Cellular Dynamics International expects to develop safe and more effective drugs.

They are used in various medical therapies and will revolutionize healthcare when it is fully understood and developed. They can differentiate into other cells such as blood cells, heart cells, neurons, etc. Stem cell assays use to analyze stem cells based on specific parameters to assess their potency's biochemical functions. FDA has the right to regularize stem cell products in the United States. The FDA has approved some products like cord blood consisting of blood-forming stem cells, which came through stem cell assays. Stem cell assays play an essential role in the treatment of several diseases.

MARKET DRIVERS

The rising demand for clinical trials for stem cell-based therapies and growing support from the public and private sectors are majorly propelling the growth rate of the global stem cell assay market.

Also, growing awareness over the availability of the different treatment procedures for damaged cells is solely leveling the market demand. The rise in the need to develop new drugs with high quality is another factor promoting the growth rate of the stem cell assay market. Rising occurrences of chronic diseases and growing investments in the biotechnology field are leveraging this market demand. 

The introduction of innovative products with advanced technology in the biotechnology field and the rise in the number of research are additional attributes that open new opportunities to the stem cell assays market. Also, increasing support from the government to develop new drugs is lucratively fueling the growth rate of the market. Increasing expenditure on health care in urban areas and rising disposable income are lucratively boosting the stem cell assay market demand. The growing focus on stem cell therapies and launching different medical sector techniques is leveraging the growth rate of the market.

MARKET RESTRAINTS:

Stringent rules and regulations by the government are one of the prominent factors in declining the growth rate of the global stem cell assay market.

Difficulty in getting approvals for the new products by health organizations slowly degrades the stem cell assay market demand. Lack of standardization is hampering the need for the stem cell assay market. Besides, these therapy techniques require enormous costs for the installation of the tools in the laboratories. The factor mentioned earlier is limiting the growth of the market to some extent. 

COVID-19 impact on the global stem cell assay market:

COVID-19 pandemic has disrupted every sector in unprecedented ways. The stem cell assay shares have been surged during this period with the growing prevalence to study the SARS-CoV-2 characteristics. The stem cell assay help applications help provide the data to develop new diagnostic tools, treatment procedures, and vaccines for COVID-19. Researchers are achieving accurate results while studying immune responses to viral infection. This helps them to develop an efficient vaccine and diagnostic tools in favor of the consumer at the earliest. As COVID-19 is new to the world, it is difficult to study the virus's complete features. Scientists are grabbing information to develop an accurate diagnostic tool using these stem cell assay techniques. Therefore, the market shares are growing tremendously since the start of COVID-19.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Assay Type, Kits, Product, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Market Leaders Profiled

Bio-Techne Corporation, Thermo Fisher Scientific Inc., Merck KGaA, STEMCELL Technologies Inc., Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs Inc.,

 

This research report on the global stem cell assay market has been segmented and sub-segmented into the assay type, kits type, product, application, end-user, and region.

Stem Cell Assay Market - By Assay Type:

  • Cell Viability and Toxicity Assays
  • Purification Assays
  • Differentiation Assays
  • Function Assays
  • Identification Assays
  • Proliferation Assays
  • Cell Apoptosis Assays

Based on Assay Type, the Cell Viability and Toxicity Assays hold a significant share during the period as there is a growth in drug testing concentration that uses stem cells. The rise in the number of research centers is also additionally promoting the demand of the market.

Stem Cell Assay Market - By Kits:

  • Adult Stem Cell Kits
    • Induced Pluripotent Stem Cell Kits
    • Mesenchymal Stem Cell Kits
    • Hematopoietic Stem Cell Kits
    • Umbilical Cord Stem Cells
    • Neuronal Stem Cell Kits
  • Human embryonic stem cell kits

Based on Kits, the adult stem cell kits hold a significant share due to an increase in the launch of new product activities and a rise in the concentration of drug identification by pharma and biotechnology industries.

Stem Cell Assay Market - By Application:

  • Regenerative Medicine
    • Dermatology
    • Cardiovascular
    • Orthopedic and Musculoskeletal Spine
    • Oncology
    • Central Nervous System
    • Diabetes
  • Therapy Development
  • Drug Discovery and development
  • Clinical research

Based on Application, the Regenerative Medicine segment holds the highest shares with increased occurrences of diseases like diabetes and cancer. The gradual development of new therapies is likely to offer better opportunities for the growth of the market.

Stem Cell Assay Market - By End-User:

  • Research Institutes
  • Industry Research

Based on End-User, the Industry Research segment holds a significant share during the period due to the high growth in following an investigation procedure. Also, testing them is driving away from the stem cell assay market.

Stem Cell Assay Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American market is expected to account for the largest share in the global stem cell assay market during the forecast period due to an increase in the aging population and surges up in chronic diseases' commonness. Furthermore, investments in the development of new drugs by both government and non-government organizations may boost the market growth.  The region is expected to maintain its dominance throughout the forecast period. The high growth rate in adopting stem cell assay and advancements in technology, increasing regular approvals for stem cell assay towards the drug testing and examining, drives the market demand. The U.S. is expected to lead the market with the highest CAGR between 2020 to 2025. Surging chronic illness and expenses made in the research and development in the biotechnology sector are the factors responsible for the market growth in U.S. Canada is to have quick growth in the market. The Canadian biotechnology company STEMCELL technology has been making a prominent contribution in battling against Corona Virus.

The European market was the second-largest stem cell assay market globally and was very next to North America in accounting majority of the market share in 2019. Among various European countries, the U.K. market is expected to dominate this regional market, followed by Germany. The market growth is based on improvements in technology, the existence of many key players and researchers of stem cell-based therapies in the European countries. Germany is scheduled to lead the market with the highest market share. The increasing aging population is exposed to several varied chronic diseases, the expanding number of government initiatives, and the launch of new reimbursement policies are escalating the market demand. The U.K. is next to Germany in ruling the stem cell assay market. Factors like growing regularity in approvals for new therapy technologies for cancer, diseases, and many others are fostering the market demand. Across the globe, the U.K is the fourth biggest donor in biotechnology research and development.

Asia-Pacific is the fastest-growing market for the stem cell assay market due to the adoption of stem-cell-based therapies. The biotechnology sector is significantly growing in the Asia Pacific nations such as India and China. This particular factor is expected to favor the stem cell assay market to grow aggressively during the forecast period. Rising quick adoption of stem cell assay, the surge in investments in research and development activities of new therapies for the high occurrence of chronic diseases mount the market growth. China is expected to have promising growth in the market during the forecast period. China has started using stem cell therapy for treating patients suffering from severe COVID-19 cases. India is projected to have notable growth in the considering years due to improvements in clinical research activities. A huge increase in the patient count is outlined to heighten the stem cell assay market in India.

The stem cell assay market in LATAM is experienced to have notable growth during the analysis period. The market growth is attributed to increasing aged people registered with different types of chronic ailments. A huge patient population in emerging countries like Brazil, Argentina, and others is escalating the growth rate of the market. The growing demand for stem cell assay and growing research by the public and private research institutes drive market growth.

The Middle East and Africa region are awaited to have a considerable growth rate in the stem cell assay market. Huge healthcare expenditure made by developed countries like Saudi Arabia, Kuwait, and Qatar bolsters the market demand.

KEY MARKET PLAYERS:

Some of the notable players dominating the global stem cell assay market profiled in this report are Bio-Techne Corporation, Thermo Fisher Scientific Inc., Merck KGaA, STEMCELL Technologies Inc., Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs, Inc.

RECENT HAPPENINGS IN THIS MARKET:

  • On September 15, 2019, Fujifilm Cellular Dynamics decided to prepare and open a ‘Cleanroom’ facility. The cleanroom can help to develop cells derived from stem cells, which pharmacies now use. The cleanroom is for workers who should protect themselves.
  • On July 01, 2019, Bio-Rad laboratories brought a new solution known as scATAC-Seq Solution. Those who carry out scientific research use this scATAC Seq solution to produce chromatin profiles from human bone marrow and blood.
  • On September 20, 2017, the Bio-Techne brand made a public statement that it is widening the Ella immunoassay platform with its new 32*4 Simple Plex cartridges. The cartridge promotes efficiency by analyzing collected samples such as serum, plasma, and cell culture.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample